BACKGROUND: The objective of this study was to define the activity and toxicity of etoposide for patients with previously treated metastatic breast cancer. METHODS: Thirty patients with measurable metastatic breast cancer who progressed after prior chemotherapy, hormonal therapy, or both, either as ...
No comments yet
Be the first to share your thoughts!